Leflunomide Tablet
Product Images NDC 72162-2409

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 72162-2409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cfa52b95 F6ee 4a2c A320 E190f716d33b 01)

FDA Label Image

. (Cfa52b95 F6ee 4a2c A320 E190f716d33b 02)

FDA Label Image

Image (Cfa52b95 F6ee 4a2c A320 E190f716d33b 03)

FDA Label Image

Image (Cfa52b95 F6ee 4a2c A320 E190f716d33b 04)

FDA Label Image

. (Cfa52b95 F6ee 4a2c A320 E190f716d33b 05)

FDA Label Image

. (Cfa52b95 F6ee 4a2c A320 E190f716d33b 06)

This is a description of the Change in Functional Ability Measure® study, which assesses improvement in functional ability using the Health Assessment Questionnaire (HAQ) Disability Index. The study involves treatments with Loflunomide (L), Methotrexate (M), Placebo (P), and Sulfasalazine (S). The text also mentions some numerical values but does not provide detailed information on the study results.*

FDA Label Image

4b95cee-6630-482c-93a4-2a489f7c0c03 (Cfa52b95 F6ee 4a2c A320 E190f716d33b 07)

FDA Label Image

Label (Lbl721622409)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.